These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2653914)

  • 1. Insulin, diabetes and hepatic very-low-density lipoprotein metabolism.
    Gibbons GF
    Biochem Soc Trans; 1989 Feb; 17(1):49-51. PubMed ID: 2653914
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein metabolism in diabetes mellitus.
    Howard BV
    J Lipid Res; 1987 Jun; 28(6):613-28. PubMed ID: 3302085
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Kelly JM; Jackson NC; Sönksen PH
    Diabetes; 1995 Sep; 44(9):1059-65. PubMed ID: 7657029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What if Minkowski had been ageusic? An alternative angle on diabetes.
    McGarry JD
    Science; 1992 Oct; 258(5083):766-70. PubMed ID: 1439783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes.
    Vergès B
    Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly.
    Gibbons GF; Brown AM; Wiggins D; Pease R
    J R Soc Med; 2002; 95 Suppl 42(Suppl 42):23-32. PubMed ID: 12216323
    [No Abstract]   [Full Text] [Related]  

  • 8. Intestinal very low density lipoprotein secretion in insulin-deficient rats.
    Risser TR; Reaven GM; Reaven EP
    Diabetes; 1978 Sep; 27(9):902-8. PubMed ID: 211062
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.
    Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM
    Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin in regulation of lipoprotein metabolism in diabetes.
    Reaven GM; Chen YD
    Diabetes Metab Rev; 1988 Nov; 4(7):639-52. PubMed ID: 3069396
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the major pathways of hepatic lipid metabolism using the perfused liver.
    Mayes PA
    Horm Metab Res; 1970; 2():Suppl 2:186-95. PubMed ID: 4340422
    [No Abstract]   [Full Text] [Related]  

  • 12. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin-dependent diabetes and lipoprotein metabolism].
    Berthezène F; Perrot L; Valentin C; Sautot G
    Journ Annu Diabetol Hotel Dieu; 1984; ():115-23. PubMed ID: 6399527
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatty acids and insulin resistance: a perfect storm.
    Koo SH; Montminy M
    Mol Cell; 2006 Feb; 21(4):449-50. PubMed ID: 16483925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased sensitivity of very-low-density lipoprotein secretion to the inhibitory effect of insulin in cultured hepatocytes from lactating rats.
    Bourgeois CS; Gibbons GF
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):737-41. PubMed ID: 8670146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.
    Sparks JD; Sparks CE; Adeli K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2104-12. PubMed ID: 22796579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
    Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
    Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone.
    Martin-Sanz P; Vance JE; Brindley DN
    Biochem J; 1990 Nov; 271(3):575-83. PubMed ID: 2244866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of insulin in the control of hepatic fatty acid and glycerolipid metabolism assessed by studies in vivo.
    Zammit VA
    Braz J Med Biol Res; 1995 Oct; 28(10):1027-31. PubMed ID: 8634673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.